DarioHealth PE Ratio 2012-2025 | DRIO
Current and historical p/e ratio for DarioHealth (DRIO) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. DarioHealth PE ratio as of December 12, 2025 is 0.00.
| DarioHealth PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-12-12 | 11.89 | 0.00 | |
| 2025-09-30 | 17.35 | $-11.16 | 0.00 |
| 2025-06-30 | 13.40 | $-13.20 | 0.00 |
| 2025-03-31 | 12.24 | $-11.20 | 0.00 |
| 2024-12-31 | 15.72 | $-12.40 | 0.00 |
| 2024-09-30 | 22.40 | $-18.80 | 0.00 |
| 2024-06-30 | 23.80 | $-23.60 | 0.00 |
| 2024-03-31 | 30.60 | $-33.60 | 0.00 |
| 2023-12-31 | 34.40 | $-20.60 | 0.00 |
| 2023-09-30 | 65.60 | $-22.60 | 0.00 |
| 2023-06-30 | 80.20 | $-25.60 | 0.00 |
| 2023-03-31 | 82.40 | $-28.80 | 0.00 |
| 2022-12-31 | 85.60 | $-52.60 | 0.00 |
| 2022-09-30 | 92.60 | $-64.20 | 0.00 |
| 2022-06-30 | 122.80 | $-75.00 | 0.00 |
| 2022-03-31 | 116.80 | $-80.00 | 0.00 |
| 2021-12-31 | 259.40 | $-83.60 | 0.00 |
| 2021-09-30 | 273.00 | $-83.00 | 0.00 |
| 2021-06-30 | 427.20 | $-73.60 | 0.00 |
| 2021-03-31 | 385.20 | $-67.40 | 0.00 |
| 2020-12-31 | 285.80 | $-80.40 | 0.00 |
| 2020-09-30 | 335.60 | $-59.20 | 0.00 |
| 2020-06-30 | 127.00 | $-69.00 | 0.00 |
| 2020-03-31 | 135.80 | $-107.40 | 0.00 |
| 2019-12-31 | 131.20 | $-136.00 | 0.00 |
| 2019-09-30 | 121.60 | $-180.00 | 0.00 |
| 2019-06-30 | 186.00 | $-224.00 | 0.00 |
| 2019-03-31 | 294.80 | $-300.00 | 0.00 |
| 2018-12-31 | 310.40 | $-320.00 | 0.00 |
| 2018-09-30 | 388.00 | $-768.00 | 0.00 |
| 2018-06-30 | 512.00 | $-820.00 | 0.00 |
| 2018-03-31 | 616.00 | $-864.00 | 0.00 |
| 2017-12-31 | 640.80 | $-604.00 | 0.00 |
| 2017-09-30 | 736.00 | $-496.00 | 0.00 |
| 2017-06-30 | 872.00 | $-500.00 | 0.00 |
| 2017-03-31 | 1204.00 | $-524.00 | 0.00 |
| 2016-12-31 | 1300.00 | $-836.00 | 0.00 |
| 2016-09-30 | 1420.00 | $-667.83 | 0.00 |
| 2016-06-30 | 2060.00 | $-903.54 | 0.00 |
| 2016-03-31 | 1724.04 | $-1,211.14 | 0.00 |
| 2015-12-31 | 3312.00 | $-1,654.68 | 0.00 |
| 2015-09-30 | 2304.00 | $-1,438.85 | 0.00 |
| 2015-06-30 | 2664.00 | $-5,827.34 | 0.00 |
| 2015-03-31 | 1908.00 | $-10,719.43 | 0.00 |
| 2014-12-31 | 1252.80 | $-15,179.86 | 0.00 |
| 2014-09-30 | 4176.00 | $-15,179.86 | 0.00 |
| 2014-06-30 | 36000.00 | $-16,546.76 | 0.00 |
| 2014-03-31 | 60840.00 | $-21,582.73 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.080B | $0.027B |
| DarioHealth Corp. creates mobile and digital tools. The company's product the Dario(TM) Smart Diabetes Management Solution, is a platform for diabetes management which combines blood glucose meter, native smart phone app, website portal and treatment tools to users living with diabetes, their doctors and healthcare systems. DarioHealth Corp., formerly known as LabStyle Innovations Corp., is based in Ramat Gan, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.010B | 25.55 |
| Intuitive Surgical (ISRG) | United States | $194.409B | 76.06 |
| IDEXX Laboratories (IDXX) | United States | $56.231B | 55.85 |
| Edwards Lifesciences (EW) | United States | $48.211B | 32.33 |
| Alcon (ALC) | Switzerland | $38.868B | 26.27 |
| IQVIA Holdings (IQV) | United States | $37.851B | 21.11 |
| Mettler-Toledo (MTD) | United States | $28.470B | 33.31 |
| DexCom (DXCM) | United States | $26.115B | 36.00 |
| STERIS (STE) | Ireland | $24.712B | 25.51 |
| Waters (WAT) | United States | $22.941B | 30.34 |
| Hologic (HOLX) | United States | $16.718B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.969B | 0.00 |
| Penumbra (PEN) | United States | $12.219B | 85.96 |
| Globus Medical (GMED) | United States | $11.604B | 24.35 |
| Masimo (MASI) | United States | $7.431B | 23.81 |
| Glaukos (GKOS) | United States | $6.253B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.835B | 18.54 |
| Teleflex (TFX) | United States | $5.607B | 8.94 |
| TransMedics (TMDX) | United States | $4.333B | 51.33 |
| LivaNova (LIVN) | United Kingdom | $3.427B | 18.51 |
| Veracyte (VCYT) | United States | $3.386B | 38.60 |
| Alphatec Holdings (ATEC) | United States | $2.965B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.548B | 11.96 |
| Elekta AB (EKTAY) | Sweden | $2.183B | 20.42 |
| Artivion (AORT) | United States | $2.138B | 98.09 |
| PROCEPT BioRobotics (PRCT) | United States | $2.011B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.826B | 15.94 |
| UFP Technologies (UFPT) | United States | $1.692B | 22.35 |
| Tandem Diabetes Care (TNDM) | United States | $1.450B | 0.00 |
| AxoGen (AXGN) | United States | $1.402B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.310B | 0.00 |
| IRadimed (IRMD) | United States | $1.224B | 58.32 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.045B | 5.66 |
| Pulse Biosciences (PLSE) | United States | $0.965B | 0.00 |
| SiBone (SIBN) | United States | $0.807B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.640B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.621B | 36.13 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.613B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.545B | 10.88 |
| AngioDynamics (ANGO) | United States | $0.541B | 0.00 |
| NeuroPace (NPCE) | United States | $0.539B | 0.00 |
| RxSight (RXST) | United States | $0.519B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.441B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.429B | 11.85 |
| Alpha Tau Medical (DRTS) | Israel | $0.428B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.428B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| ClearPoint Neuro (CLPT) | United States | $0.361B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.275B | 2.05 |
| Spectral Diagnostics (EDTXF) | Canada | $0.269B | 0.00 |
| CVRx (CVRX) | United States | $0.221B | 0.00 |
| 908 Devices (MASS) | United States | $0.216B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.211B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.178B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.160B | 0.00 |
| Solana (HSDT) | United States | $0.139B | 0.00 |
| LENSAR (LNSR) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.120B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.109B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Neuronetics (STIM) | United States | $0.104B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| InspireMD (NSPR) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.023B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.35 |